河北建新化工股份有限公司 证劵代码：300107 证劵简称：建新股份 公告编号：2023-023 欢迎广大投资者积极参与！ 特此公告。 河北建新化工股份有限公司 董 事 会 二○二三年四月十三日 关于举行2022年度业绩网上说明会的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 河北建新化工股份有限公司（以下简称"公司"）于 2023 年 4 月 15 日在中 国证监会指定创业板信息披露网站巨潮资讯网(www.cninfo.com.cn)披露了 《2022 年年度报告》全文及其摘要等相关文件，为使投资者能够进一步了解公 司的生产经营等情况，公司定于 2023 年 5 月 5 日（星期五）下午 15:00-17:00 在全景网举行 2022 年度业绩网上说明会，本次年度业绩说明会将采用网络远程 的方式举行，投资者可登陆"全景·路演天下"（http://rs.p5w.net）参与本 次说明会。 出席本次年度业绩说明会的人员有：公司董事长朱守琛先生、总经理兼董事 会秘书陈学为先生、财务总监高辉女士、公司独立董事张先中先生。 ...

Financial Performance - The company's revenue for Q3 2022 reached ¥176,401,072.48, representing a 36.80% increase compared to the same period last year[5] - Net profit attributable to shareholders was ¥13,379,181.43, a significant increase of 1,052.19% year-on-year[5] - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥11,498,152.52, up 1,305.75% from the previous year[5] - The basic earnings per share for Q3 2022 was ¥0.0242, reflecting a 1,052.38% increase compared to the same period last year[5] - Operating revenue for the first nine months of 2022 reached ¥554.60 million, a 31.42% increase compared to ¥422.01 million in the same period of 2021, primarily due to rising sales prices of main products[11] - Net profit for the first nine months of 2022 was ¥48.68 million, representing a 486.18% increase from ¥8.31 million in the same period of 2021, driven by higher sales prices and improved gross margin[11] - Total profit for the first nine months of 2022 was ¥57.42 million, a remarkable increase of 556.04% from ¥8.75 million in the same period of 2021, attributed to higher sales prices and improved gross margin[11] - The net profit for the third quarter of 2022 was CNY 48,684,942.75, a significant increase from CNY 8,305,511.01 in the same period last year, representing a growth of approximately 485%[23] - Operating profit for the third quarter was CNY 57,630,344.60, compared to CNY 8,253,488.02 in the previous year, indicating a year-over-year increase of about 596%[23] - The total profit for the third quarter was CNY 57,420,904.62, up from CNY 8,752,710.13 in the same period last year, representing a growth of approximately 554%[23] Assets and Liabilities - Total assets at the end of Q3 2022 amounted to ¥1,557,874,654.45, a decrease of 2.07% from the end of the previous year[5] - The company's total assets as of September 30, 2022, were CNY 1,557,874,654.45, a decrease from CNY 1,590,772,108.66 at the beginning of the year[21] - Total liabilities decreased to CNY 113,730,833.53 from CNY 148,077,838.68, indicating a reduction of approximately 23.1%[20] - The company's cash and cash equivalents decreased to CNY 394,406,730.47 from CNY 513,079,183.72, a decline of 23.1%[19] - Inventory levels were reported at CNY 98,090,810.17, slightly down from CNY 100,988,014.09, a decrease of 1.9%[19] - The total equity attributable to shareholders increased marginally to CNY 1,444,143,820.92 from CNY 1,442,694,269.98[21] Cash Flow - The company’s cash flow from operating activities for the year-to-date was ¥117,954,774.43, showing a slight increase of 1.93%[5] - The net cash flow from operating activities was ¥117.95 million, a slight increase of 1.93% from ¥115.72 million in the previous year[12] - The net cash flow from investing activities improved by 51.33%, reaching -¥136.58 million, compared to -¥280.64 million in the same period of 2021, primarily due to reduced intangible asset investments[12] - The company reported a net cash outflow from investing activities of CNY -136,580,025.59, an improvement from CNY -280,638,831.11 in the same period last year[25] - Cash and cash equivalents at the end of the period totaled CNY 244,406,730.47, down from CNY 308,805,224.75 at the end of the previous year[25] - The company experienced a cash outflow from financing activities of CNY -133,537,817.01, compared to CNY -93,080,085.82 in the previous year, indicating increased financing costs[25] Research and Development - Research and development expenses surged by 94.94% to ¥25.86 million in the first nine months of 2022, up from ¥13.26 million in the same period of 2021, indicating increased investment in R&D[11] - Research and development expenses increased significantly to CNY 25,856,533.48, compared to CNY 13,264,063.02 in the same period last year, reflecting a growth of 95.5%[22] - The company plans to continue focusing on R&D and market expansion strategies to drive future growth[22] Investments - The company reported a 120.00% increase in trading financial assets, totaling ¥110,000,000.00, primarily due to increased investment in financial products[9] - Investment income increased significantly by 2210.36% to ¥1.41 million, compared to ¥61,090.34 in the previous year, mainly due to increased bank wealth management investments[11] - The company received CNY 122,550,000.00 from the recovery of investments, a significant increase from CNY 26,000,000.00 in the previous year, indicating a strong investment recovery[24] Shareholder Information - The company has implemented a stock option and restricted stock incentive plan, granting 7.26 million stock options to 78 incentive objects on July 18, 2022[15] - The total number of ordinary shareholders at the end of the reporting period was 25,992, with the largest shareholder holding 39.11% of the shares[13]

Financial Performance - The company's operating revenue for the first half of 2022 was ¥378,201,946.89, representing a 29.05% increase compared to ¥293,055,196.18 in the same period last year[22]. - The net profit attributable to shareholders of the listed company reached ¥35,305,761.32, a significant increase of 394.18% from ¥7,144,319.58 in the previous year[22]. - The net profit after deducting non-recurring gains and losses was ¥33,849,539.65, up 701.19% from ¥4,224,914.03 in the same period last year[22]. - The basic earnings per share increased to ¥0.0640, a rise of 392.31% compared to ¥0.0130 in the previous year[22]. - The total operating revenue for the first half of 2022 was CNY 378,201,946.89, an increase of 29.1% compared to CNY 293,055,196.18 in the same period of 2021[137]. - The total operating costs for the first half of 2022 were CNY 338,227,612.80, up from CNY 289,276,858.65 in the first half of 2021, reflecting a rise of 16.9%[137]. - The net profit for the first half of 2022 was CNY 35,305,761.32, compared to CNY 7,144,319.58 in the same period of 2021, indicating a significant increase[138]. - The total comprehensive income for the period was CNY 37,410,092.24, compared to CNY 7,813,400.14 in the same period last year, an increase of 377.5%[143]. Assets and Liabilities - The total assets at the end of the reporting period were ¥1,588,464,177.18, a slight decrease of 0.15% from ¥1,590,772,108.66 at the end of the previous year[22]. - The total assets as of June 30, 2022, were CNY 1,593,827,797.64, slightly down from CNY 1,594,031,398.20 at the start of the year[135]. - The total liabilities increased to CNY 165,323,231.27 as of June 30, 2022, compared to CNY 148,073,445.24 at the beginning of the year, representing an increase of 11.3%[136]. - The total liabilities at the end of the reporting period were 1.2 billion yuan, maintaining a manageable debt level[152]. Cash Flow - The net cash flow from operating activities was ¥74,547,016.06, down 10.77% from ¥83,543,888.93 in the same period last year[22]. - The net cash flow from operating activities for the first half of 2022 was CNY 75,244,429.19, a decrease of 9.4% compared to CNY 83,532,139.55 in the same period of 2021[147]. - The total cash inflow from operating activities was CNY 266,022,616.06, down 39% from CNY 436,287,394.99 year-on-year[147]. - The net cash flow from investment activities was -CNY 114,169,292.25, improving from -CNY 199,729,712.46 in the first half of 2021[148]. - The net cash flow from financing activities was -CNY 78,496,908.34, an improvement from -CNY 157,200,085.68 in the first half of 2021[148]. Research and Development - The company has increased its R&D investment to drive market expansion and improve product competitiveness[35]. - Research and development investment increased by 44.20% to ¥16.96 million from ¥11.76 million, reflecting the company's commitment to innovation and new profit growth points[44]. - The company has initiated research and development for new technologies aimed at enhancing production efficiency[152]. Market Strategy and Operations - The company has focused on enhancing operational efficiency and management levels to counteract rising raw material costs and ensure stable profit growth[35]. - The company aims to optimize its industrial chain structure with a strategy of "expanding horizontally and strengthening vertically"[34]. - The company is positioned in the fine chemical industry, with its products serving as intermediates for various applications in pharmaceuticals, dyes, and composite materials[30]. - The company plans to expand its market presence and invest in new product development to drive future growth[152]. Environmental and Social Responsibility - The company is committed to increasing investment in environmental protection to meet stricter regulatory standards[67]. - The company has established a comprehensive safety production system to mitigate risks associated with the use of flammable and explosive chemicals[68]. - The company actively fulfills social responsibilities, integrating economic development with social responsibility, and has been recognized for its sincere return to shareholders, ranking first in the "Sincere Return List" by the China Listed Companies Association[82]. Shareholder Information - The company did not distribute cash dividends or bonus shares for the first half of 2022[74]. - The total number of shareholders at the end of the reporting period was 26,919, with no preferred shareholders having restored voting rights[116]. - The largest shareholder, Zhu Shouchan, holds 39.11% of the shares, totaling 215,768,643 shares[116]. Risks and Challenges - The management has highlighted potential macro policy risks and market risks that may impact the company's performance[3]. - The company is facing risks related to macroeconomic policies, market demand fluctuations, and potential impacts from the COVID-19 pandemic[65]. - The company is closely monitoring foreign exchange fluctuations to mitigate risks associated with its export business[66].

Financial Performance - The company's revenue for Q1 2022 was CNY 164,880,447.49, representing a 3.69% increase compared to CNY 159,012,462.67 in the same period last year[4] - Net profit attributable to shareholders increased by 186.79% to CNY 10,869,146.47 from CNY 3,789,913.09 year-on-year[4] - The total profit for the period was CNY 12,158,781.45, reflecting a 257.81% increase from CNY 3,398,077.19 in the same period last year[10] - Net profit for Q1 2022 reached CNY 10,869,146.47, a significant increase of 187.5% compared to CNY 3,789,913.09 in the same period last year[22] - Basic and diluted earnings per share for Q1 2022 were both CNY 0.0197, up from CNY 0.0069 in Q1 2021[23] Cash Flow - The net cash flow from operating activities surged by 285.92% to CNY 34,330,538.40, up from CNY 8,895,663.30 in Q1 2021[4] - Cash inflow from operating activities totaled CNY 113,204,651.47, compared to CNY 238,838,322.53 in the previous year, indicating a decrease of 52.7%[24] - The cash flow from operating activities showed a positive trend, with a total outflow of CNY 78,874,113.07, down from CNY 229,942,659.23 in the previous year[26] - The company's total tax payments amounted to CNY 952,076.71, slightly lower than CNY 985,152.30 in Q1 2021[26] Assets and Liabilities - Total assets at the end of the reporting period were CNY 1,604,678,072.05, a 0.87% increase from CNY 1,590,772,108.66 at the end of the previous year[4] - The total liabilities increased to CNY 151,114,655.60 from CNY 148,077,838.68, marking a rise of 2.1%[22] - Current assets totaled CNY 826,129,950.29, slightly up from CNY 819,836,872.13 at the start of the year[18] - The total cash outflow from investing activities was CNY 86,193,096.38, compared to CNY 158,050,816.58 in the previous year, indicating a reduction in investment expenditures[26] Shareholder Information - The number of ordinary shareholders at the end of the reporting period was 27,795[11] - The number of shares held by the top shareholder, Zhu Shouchan, is 53,942,161 ordinary shares[14] - The company has a total of 214,239,647 restricted shares, with no new restrictions added during the period[15] Operational Efficiency - The company experienced a 421.79% increase in taxes and surcharges, amounting to CNY 2,306,059.50, primarily due to increased tax liabilities[9] - Research and development expenses for Q1 2022 were CNY 4,994,296.90, down from CNY 6,895,845.41, reflecting a decrease of 27.6%[21] - The company's fixed assets were valued at CNY 438,833,965.60, down from CNY 454,931,669.96[18] Investment Income - Investment income surged by 7068.86% to CNY 396,676.84, driven by increased bank wealth management investments[10]

Financial Performance - The company's operating revenue for 2021 was CNY 628,149,906.61, an increase of 11.43% compared to CNY 563,706,641.61 in 2020[24]. - The net profit attributable to shareholders for 2021 was CNY 13,643,293.97, a decrease of 69.95% from CNY 45,407,995.41 in 2020[24]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was CNY 5,222,597.50, down 89.21% from CNY 48,386,671.27 in 2020[24]. - The net cash flow from operating activities was CNY 191,719,039.31, a decline of 31.58% compared to CNY 280,205,960.83 in 2020[24]. - The total assets at the end of 2021 were CNY 1,590,772,108.66, a slight decrease of 0.38% from CNY 1,596,913,103.91 at the end of 2020[24]. - The net assets attributable to shareholders at the end of 2021 were CNY 1,442,694,269.98, down 2.60% from CNY 1,481,154,766.47 at the end of 2020[24]. - The basic earnings per share for 2021 were CNY 0.0247, a decrease of 70.10% from CNY 0.0826 in 2020[24]. - The diluted earnings per share for 2021 were CNY 0.0247, down 70.06% from CNY 0.0825 in 2020[24]. - The weighted average return on equity for 2021 was 0.94%, a decrease of 1.97% from 2.91% in 2020[24]. - The company reported a total of CNY 8,420,696.47 in non-recurring gains and losses for 2021, compared to a loss of CNY 2,978,675.86 in 2020[30]. Market and Sales Strategy - The company will focus on improving management levels and expanding domestic and international markets to enhance profitability and market share[7]. - The company aims to enhance its market share by adjusting sales strategies in response to domestic and international market demand changes[36]. - The company emphasizes a direct sales model supported by a professional sales and after-sales service team[40]. - The company’s production model combines sales-driven production with promotional efforts to optimize inventory management[40]. - Domestic sales accounted for 47.87% of total revenue, while international sales made up 52.13%, with a year-on-year increase of 19.34% in international sales[61]. Research and Development - The company plans to increase R&D investment to enrich product variety and optimize product structure, aiming to reduce production costs and enhance product competitiveness[5]. - The company is committed to continuous technological innovation and the development of new products to improve overall performance[36]. - The company completed the development of a new color developer product, JX-201, which is expected to enhance market competitiveness[73]. - The company is advancing the continuous production process for sulfonation of nitrobenzene, aiming to improve safety and efficiency[74]. - The company has 14 invention patents, 31 utility model patents, and 35 proprietary technologies, forming a core technology system with independent intellectual property rights[48]. Environmental and Safety Management - The company will increase investment in environmental protection to comply with stricter regulations and improve overall environmental awareness[8]. - The company has established a comprehensive safety production system to mitigate risks associated with the use of flammable and explosive chemicals in its production processes[9]. - The company has achieved a resource utilization rate of 80% for industrial wastewater through its patented treatment facility, ensuring compliance with national regulations[49]. - The company emphasizes social responsibility by integrating economic development with environmental protection and stakeholder engagement[163]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[162]. Talent and Human Resources - The company emphasizes the importance of attracting and cultivating high-quality technical and management talent to address potential talent shortages as it expands[7]. - The company has established a comprehensive human resources management system to attract and retain talent, enhancing its operational capabilities[57]. - The company plans to focus on employee development through stock incentive plans and recruitment of high-end professionals to support innovation and product development[100]. - The company has implemented a salary management system that considers both employee interests and market conditions, with a focus on high-risk and high-responsibility positions[135]. Governance and Management - The company’s governance structure complies with legal and regulatory requirements without significant discrepancies[107]. - The company has established an independent financial department with a separate accounting system and financial management policies[109]. - The company has a total of six independent directors, each receiving CNY 5 million in remuneration[122]. - The company held its annual general meeting with a participation rate of 48.18% on May 14, 2021[110]. - The company has not faced any disciplinary actions from the China Securities Regulatory Commission regarding internal control issues in 2021[107]. Future Outlook and Strategic Initiatives - The company plans to increase its investment in Cangzhou Jianxin Ruixiang by 130 million yuan to support its operations[94]. - The company aims to solidify existing customer relationships while developing new ones and optimizing market layout to enhance product quality and brand effect[101]. - The company plans to accelerate new product development and expand production scale to improve market competitiveness and risk resistance amid industry changes[97]. - The company is exploring potential mergers and acquisitions to strengthen its market position and diversify its product offerings[196]. - The company anticipates a revenue growth target of 20% for the next fiscal year, driven by increased demand in the chemical sector[197].

Financial Performance - The company's revenue for Q3 2021 was ¥128,950,530.72, representing a 10.90% increase compared to the same period last year[3]. - Net profit attributable to shareholders for Q3 2021 was ¥1,161,191.43, a 15.42% increase year-on-year, but a significant decline of 85.23% compared to the year-to-date figure[3]. - Total operating revenue for the third quarter was CNY 422,005,726.90, a decrease of 0.64% compared to CNY 424,734,584.95 in the previous year[21]. - Net profit for the third quarter was CNY 8,305,511.01, a significant decline of 85.2% compared to CNY 56,174,546.14 in the previous year[22]. - Basic and diluted earnings per share were both CNY 0.0151, down from CNY 0.1021 in the same quarter last year[23]. Cash Flow - The net cash flow from operating activities for the year-to-date period was ¥115,717,304.48, down 31.73% from the previous year[9]. - The net cash flow from operating activities for Q3 2021 was ¥115,717,304.48, a decrease of 31.7% compared to ¥169,493,569.36 in Q3 2020[26]. - Total cash inflow from investment activities was ¥26,071,206.99, significantly lower than ¥329,042,310.94 in the same period last year[27]. - The net cash flow from financing activities was -¥93,080,085.82, compared to -¥360,063,282.35 in Q3 2020, indicating an improvement[27]. - The company reported cash inflow from other operating activities of ¥252,777,014.76, down from ¥457,632,168.16 in Q3 2020[26]. Assets and Liabilities - Total assets at the end of Q3 2021 were ¥1,587,800,098.96, a decrease of 0.57% from the end of the previous year[4]. - Total current assets decreased from 1,036,959,642.65 RMB at the end of 2020 to 832,457,446.54 RMB, a decrease of about 19.7%[17]. - Total liabilities amounted to CNY 151,407,356.30, up from CNY 115,758,337.44 in the previous year[19]. - The company's total liabilities increased, with contract liabilities rising by 74.78% to ¥4,978,814.23, reflecting an increase in customer payments received[8]. Shareholder Information - Total number of common shareholders at the end of the reporting period is 33,009[12]. - The largest shareholder, Zhu Shouchan, holds 39.11% of shares, totaling 215,768,643 shares[12]. - The company has a total of 214,277,147 shares under lock-up agreements at the end of the reporting period[14]. - Zhu Shouchan's locked shares amount to 161,826,482, which are subject to restrictions due to his position[14]. Research and Development - The company's research and development expenses decreased by 33.81% to ¥13,264,063.02 for the year-to-date period[9]. - Research and development expenses were CNY 13,264,063.02, down from CNY 20,040,409.09 in the same period last year[22]. Other Financial Metrics - The company reported a significant increase in other income, up 126.49% to ¥3,270,801.82, primarily due to increased government subsidies[9]. - The company experienced a 94.93% decrease in investment income, down to ¥61,090.34, attributed to reduced bank wealth management investments[9]. - The company received tax refunds amounting to ¥28,294,292.30 in Q3 2021, compared to ¥11,988,946.95 in Q3 2020, reflecting a 136.5% increase[26]. - Cash outflow for purchasing goods and services was ¥164,101,428.06, an increase from ¥106,280,129.86 in the previous year[26]. - Cash outflow for financing activities, including dividend payments, was ¥55,432,265.79, a significant decrease from ¥330,072,093.59 in Q3 2020[27]. Audit and Compliance - The company did not conduct an audit for the Q3 2021 report[28]. - The company has not applied the new leasing standards for the financial statements as of 2021[28].

Financial Performance - The company's operating revenue for the first half of 2021 was approximately ¥293.06 million, a decrease of 4.99% compared to the same period last year[23]. - The net profit attributable to shareholders of the listed company was approximately ¥7.14 million, down 87.07% year-on-year[23]. - The net profit after deducting non-recurring gains and losses was approximately ¥4.22 million, a decline of 92.21% compared to the previous year[23]. - The net cash flow from operating activities was approximately ¥83.54 million, a decrease of 15.93% from the same period last year[23]. - The basic earnings per share were ¥0.0130, down 87.06% year-on-year[23]. - The total profit for the first half of 2021 was CNY 6,927,772.64, down from CNY 63,506,836.33 in the same period of 2020, indicating a decline of over 89%[158]. - The net profit for the first half of 2021 was CNY 7,144,319.58, compared to CNY 55,207,400.72 in the first half of 2020, reflecting a significant decline[158]. - The gross profit margin decreased, with operating costs rising to CNY 259,763,487.03 from CNY 218,666,308.62, indicating a 19% increase in costs[160]. Assets and Liabilities - Total assets at the end of the reporting period were approximately ¥1.58 billion, a decrease of 1.18% from the end of the previous year[23]. - The net assets attributable to shareholders of the listed company were approximately ¥1.43 billion, down 3.22% from the previous year[23]. - At the end of the reporting period, cash and cash equivalents amounted to ¥615,750,566.04, representing 39.02% of total assets, a decrease of 12.79% compared to the previous year[48]. - Accounts receivable increased to ¥93,925,614.72, accounting for 5.95% of total assets, up by 2.65% from the previous year[48]. - Inventory decreased to ¥79,557,509.24, making up 5.04% of total assets, down by 1.90% compared to the previous year[48]. - The total liabilities were not specified in the provided data, but the accounts payable decreased to CNY 35,743,997.53 from CNY 50,887,151.55, indicating a reduction of about 29.6%[148]. Investment and R&D - Research and development investment decreased by 24.24% to ¥11,762,236.98 from ¥15,525,001.66[45]. - The company plans to increase investment in the composite materials sector and enhance market share of intermediate products[31]. - The company aims to enhance its management capabilities and R&D investment to improve product competitiveness and market share[74]. Market and Operations - The company focuses on the production and sales of benzene-based intermediates, with products used in pharmaceuticals, pesticides, dyes, and paper chemicals[30]. - The company maintains long-term stable partnerships with global chemical giants, selling products in over 20 countries and regions[30]. - The company is positioned in the middle of the industrial chain, benefiting from the optimization of the fine chemical industry structure[35]. - The company is involved in the production and sale of various chemical products, including electronic chemicals and new materials[69]. Risk Management - The company has acknowledged various macro policy risks and market risks that may impact its operations[6]. - The company is facing macro policy risks due to the ongoing impact of the COVID-19 pandemic on global economic recovery, which may affect product exports[73]. - The company is exposed to exchange rate risks due to a significant portion of its exports being settled in USD, and it will monitor foreign exchange trends closely[74]. - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[75]. Environmental and Social Responsibility - The company is committed to increasing environmental protection investments to meet stricter regulatory standards in the fine chemical industry[75]. - The company has implemented strict environmental monitoring and management measures, ensuring compliance with pollution discharge standards and optimizing existing facilities to improve treatment efficiency[93]. - The company actively engages in social responsibility initiatives, including employment creation, tax contributions, and community support projects such as drinking water improvements and public lighting installations[97]. Shareholder and Equity Information - The company did not distribute cash dividends or bonus shares for the half-year period[80]. - The total number of shares increased to 551,251,422, with an increase of 1,800 shares due to stock options and restricted stock plan exercises[128]. - The largest shareholder, Zhu Shouchan, holds 39.14% of the shares, totaling 161,826,482 shares[133]. - The company has implemented a stock option and restricted stock incentive plan approved on August 25, 2020[128]. Financial Reporting and Compliance - The semi-annual financial report was not audited[104]. - The financial statements reflect the company's financial position and operating results as of June 30, 2021, in accordance with the disclosure requirements[198]. - The financial statements are prepared based on the going concern assumption and comply with the relevant accounting standards[195].

Financial Performance - The company's revenue for Q1 2021 was ¥159,012,462.67, representing a 0.73% increase compared to ¥157,856,922.15 in the same period last year[9] - Net profit attributable to shareholders decreased by 86.31% to ¥3,789,913.09 from ¥27,693,911.54 year-on-year[9] - The net profit after deducting non-recurring gains and losses fell by 87.75% to ¥3,427,166.39 compared to ¥27,972,159.53 in the previous year[9] - Basic and diluted earnings per share both decreased by 86.00% to ¥0.007 from ¥0.050 year-on-year[9] - The net profit for the reporting period was ¥3,789,913.09, a decrease of 86.30% year-on-year, primarily due to a decline in the sales price of main products and a reduction in gross margin[19] - The total profit for the reporting period was ¥3,398,077.19, a decrease of 89.27% year-on-year, attributed to lower sales prices of main products[19] - The total operating revenue for Q1 2021 was CNY 159,012,462.67, a slight increase from CNY 157,856,922.15 in the same period last year, representing a growth of approximately 0.73%[48] - The net profit for Q1 2021 was CNY 3,789,913.09, a significant decrease from CNY 27,655,661.41 in Q1 2020, reflecting a decline of approximately 86.29%[50] Cash Flow - The net cash flow from operating activities improved significantly to ¥8,895,663.30, a turnaround from a negative cash flow of ¥137,441,984.35 in the same period last year, marking a 106.47% increase[9] - Operating cash flow net amount was ¥8,895,663.30, an increase of 106.47% compared to the same period last year, mainly due to reduced tax payments[19] - The net cash flow from operating activities was approximately ¥8.90 million, a recovery from a negative cash flow of ¥137.44 million in the same period last year[58] - The total cash inflow from operating activities decreased to 238,831,649.06 from 443,507,063.59, representing a decline of approximately 46.1%[61] - Cash outflow from operating activities also decreased to 229,938,146.06 from 580,461,057.47, a reduction of about 60.4%[61] Assets and Liabilities - The total assets at the end of the reporting period were ¥1,624,695,410.53, an increase of 1.74% from ¥1,596,913,103.91 at the end of the previous year[9] - The company's total assets amounted to CNY 1,624,695,410.53, an increase from CNY 1,596,913,103.91 as of December 31, 2020, reflecting a growth of approximately 1.5%[40] - The company's current assets totaled CNY 1,042,626,817.62, slightly up from CNY 1,036,959,642.65 at the end of 2020, indicating a marginal increase of about 0.7%[40] - The company's total liabilities were reported at CNY 139,110,837.82, compared to CNY 115,758,337.44 at the end of 2020, reflecting an increase of about 20.1%[42] - The total liabilities as of March 31, 2021, were CNY 139,106,444.38, up from CNY 115,753,944.00 at the end of 2020, representing an increase of approximately 20.14%[46] Shareholder Information - The total number of ordinary shareholders at the end of the reporting period was 29,773[11] - The largest shareholder, Zhu Shouchan, holds 39.14% of the shares, totaling 215,768,643 shares[11] - The company has not seen any share reduction from a major shareholder despite a planned reduction announced earlier[26] Investment and R&D - The company plans to enhance product research and development and technology innovation to strengthen its competitive advantage[23] - The company plans to increase R&D investment and optimize product structure to enhance market competitiveness amid uncertainties caused by the COVID-19 pandemic[24] - The company will invest RMB 130 million in its wholly-owned subsidiary, Cangzhou Jianxin Ruixiang Chemical Technology Co., Ltd., to strengthen its capital base[27] - Cangzhou Jianxin successfully acquired land use rights for RMB 142.13 million, enhancing its operational capacity[28] Risks and Challenges - The company is facing risks related to talent shortages, particularly in high-quality technical and management personnel, which may hinder future development[24] - The company is closely monitoring foreign exchange fluctuations to minimize the impact of currency risk on its export business[24] - The company is committed to increasing environmental protection investments to meet stricter regulatory standards in the fine chemical industry[25] - The company has established comprehensive safety production regulations to mitigate risks associated with the use of flammable and explosive chemicals[25] Other Financial Information - The cash flow from investment activities was -¥158,050,816.58, a decrease of 320.90% year-on-year, mainly due to increased cash payments for land use rights[19] - The company reported a financial income of CNY 4,164,626.09, down from CNY 6,595,172.08 in the previous year, a decrease of about 36.93%[49] - The company incurred a credit impairment loss of approximately ¥1.16 million, compared to ¥0.94 million in the previous year[54] - The company did not undergo an audit for the first quarter report[63] - The company implemented new leasing standards starting in 2021, but it is not applicable for retrospective adjustments[63]

Financial Performance - The overall production and sales volume of major products increased in 2020, but due to significant declines in sales prices, gross profit margins decreased, leading to a notable reduction in sales revenue and net profit compared to the previous year[6]. - The company's operating revenue for 2020 was ¥563,706,641.61, a decrease of 39.07% compared to ¥925,158,518.22 in 2019[23]. - The net profit attributable to shareholders in 2020 was ¥45,407,995.41, down 86.05% from ¥325,577,386.27 in 2019[23]. - The net cash flow from operating activities was ¥280,205,960.83, a decline of 27.24% compared to ¥385,097,160.00 in 2019[23]. - The total assets at the end of 2020 were ¥1,596,913,103.91, a decrease of 14.11% from ¥1,859,328,958.49 at the end of 2019[23]. - The net assets attributable to shareholders decreased by 15.50% to ¥1,481,154,766.47 at the end of 2020 from ¥1,752,835,971.07 at the end of 2019[23]. - The basic earnings per share for 2020 was ¥0.0826, down 86.08% from ¥0.5932 in 2019[23]. - The diluted earnings per share for 2020 was ¥0.0825, a decrease of 85.94% compared to ¥0.5867 in 2019[23]. - The weighted average return on equity was 2.91% in 2020, down from 19.87% in 2019, a decline of 16.96%[23]. - The total profit for 2020 was CNY 50.18 million, down 86.74% year-on-year[48]. - The company’s revenue from other operating income was reported at -9,294,842.60, indicating a loss in this category[30]. Research and Development - The company plans to increase R&D investment to enrich product varieties and optimize product structure, aiming to enhance product competitiveness through technological advancements[6]. - The company has established a mature and efficient R&D innovation system, focusing on new product development and environmental improvements[52]. - The company has implemented automation upgrades in key projects, significantly improving production efficiency and reducing costs[50]. - The company has established partnerships with institutions like Tsinghua University to enhance R&D capabilities and drive innovation[48]. - The number of R&D personnel increased to 141, accounting for 15.75% of the total workforce[74]. - In 2020, the company's R&D investment amounted to CNY 24.82 million, representing 4.4% of total revenue[74]. - Research and development expenses decreased by 34.10% to ¥24.82 million, primarily due to reduced investment in R&D activities[73]. Market Strategy and Operations - The company is actively monitoring national industrial policies to adjust its development strategy in response to macroeconomic risks, including the impacts of the COVID-19 pandemic and the complexity of the US-China trade war[7]. - The company aims to improve management levels and enhance R&D capabilities to increase market share and safeguard profitability amid uncertainties in customer production due to the pandemic[7]. - The company plans to increase investment in the composite materials sector, focusing on research and development to enhance market share[34]. - The company’s main business includes the production and sales of benzene-based intermediates, with products used in pharmaceuticals, pesticides, dyes, and paper chemicals[33]. - The company has established long-term stable partnerships with global chemical giants, with products sold in over 20 countries and regions[33]. - The company’s sales model is primarily direct sales, supported by a professional sales team of 20 and a service team of 30[38]. - The company is focusing on expanding its market share through strategic investments in new technologies and product development[85]. Environmental and Safety Measures - The company is focused on environmental protection and plans to increase investment in environmental governance to meet stricter regulatory standards[9]. - The company is committed to enhancing safety production measures and reducing risks associated with the handling of flammable and explosive chemicals[10]. - The company has developed a complete set of wastewater treatment facilities, achieving 80% resource reuse of industrial wastewater[45]. - The company has implemented strict environmental protection measures during project construction, ensuring that pollution control facilities are installed and operated in accordance with environmental assessments[175]. - The company has established a quarterly monitoring program for emissions, including online detection devices for COD and ammonia nitrogen at wastewater discharge points[175]. - The company has maintained a 100% certification rate for special operations personnel, ensuring compliance with safety regulations[172]. - The company has established a comprehensive safety management system, achieving zero major safety incidents during the reporting period[172]. Financial Management and Investments - The company completed a capital increase to support long-term funding needs, enhancing its financial stability[85]. - The company has committed to invest in projects with a total funding of 27,173.5 million CNY, achieving 99.98% of the planned investment[95]. - The company has excess raised funds of RMB 332.33 million, with RMB 30 million allocated for permanent working capital[90]. - The company has approved the use of up to CNY 110 million of temporarily idle excess funds for cash management[101]. - The company has entrusted 226.4 million RMB in bank wealth management products during the reporting period, with no overdue amounts[160]. - The company has not reported any major changes or risks related to its contracts or financial management during the reporting period[159]. Shareholder and Dividend Information - The profit distribution plan approved by the board is to distribute a cash dividend of 1 RMB per 10 shares (including tax) based on a total of 551,249,622 shares[10]. - The cash dividend amount distributed in 2020 accounted for 100% of the distributable profit of 580,666,485.26 yuan[128]. - The cash dividend payout ratio for 2020 was 121.40% of the net profit attributable to ordinary shareholders[130]. - The company has established a cash dividend policy that complies with its articles of association and shareholder resolutions[126]. - The company is in a growth phase and has significant capital expenditure plans, maintaining a minimum cash dividend ratio of 20%[126]. Corporate Governance and Compliance - The company has a comprehensive internal governance structure and has strengthened budget management and cost control measures[52]. - The company has made commitments to avoid conflicts of interest and has adhered to these commitments during the reporting period[131]. - The company has appointed Zhongshen Zhonghuan Accounting Firm (Special General Partnership) for auditing services, with a fee of 390,000 RMB and a continuous service period of 2 years[136]. - There are no significant litigation or arbitration matters reported for the year[138]. - The company has not faced any penalties or rectification issues during the reporting period[139]. Social Responsibility - The company reported a comprehensive commitment to social responsibility, integrating economic development with stakeholder interests, including environmental protection and employee rights[167]. - The company donated ¥800,000 to support COVID-19 prevention efforts, demonstrating its commitment to social responsibility[53]. - The company has not initiated any targeted poverty alleviation programs during the reporting year[173].

河北建新化工股份有限公司 2020 年第三季度报告全文 河北建新化工股份有限公司 2020 年第三季度报告 2020-060 2020 年 10 月 1 河北建新化工股份有限公司 2020 年第三季度报告全文 第一节 重要提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真 实、准确、完整，不存在虚假记载、误导性陈述或者重大遗漏，并承担个别和 连带的法律责任。 所有董事均已出席了审议本次季报的董事会会议。 公司负责人朱守琛、主管会计工作负责人高辉及会计机构负责人(会计主管 人员)高辉声明：保证季度报告中财务报表的真实、准确、完整。 2 河北建新化工股份有限公司 2020 年第三季度报告全文 第二节 公司基本情况 一、主要会计数据和财务指标 公司是否需追溯调整或重述以前年度会计数据 河北建新化工股份有限公司 2020 年第三季度报告全文 说明原因 □ 适用 √ 不适用 □ 是 √ 否 | | 本报告期末 | 上年度末 | | 本报告期末比上年度末增 | | --- | --- | --- | --- | --- | | | | | | 减 | | 总资产（元） | 1,637,313,512. ...